Summary
Immunohistochemical localization of plasminogen activator inhibitor-1 (PAI-1) was studied using the streptavidin-biotin method in human atherosclerotic coronary arteries. The patients (one male and two females), whose ages ranged from 61 to 78 years, died of anteroseptal acute myocardial infarction without having received any thrombolytic therapy. PAI-1 immunoreactivities (IRs) were mainly detected in the endothelial cells, smooth muscle cells, and collagen fibers of the coronary arterial intima and not in thrombi. Remarkable immunohistochemical staining was seen in intimal collagen fibers. In one patient, intimal PAI-1 IRs partly bordered a thrombus and surrounded a large atheroma rich in cholesterol crystals. Our results suggest that PAI-1 is present in both cellular and extracellular components of human coronary atherosclerotic lesions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76:142–154
Sprengers ED, Kluft C (1987) Plasminogen activator inhibitors. Blood 69:381–387
Edelberg JM, Reilly CF, Pizzo SV (1991) The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. J Biol Chem 266:7488–7493
Hamsten A, Wiman B, Faire U, Blombäck M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557–1563
Paramo Ja, Colucci M, Collen D (1985) Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J 291:573–574
Andreotti F, Davies GJ, Hackett DR, Khan MI, De Bart ACW, Aber VR, Maseri A, Kluft C (1988) Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death, and stroke. Am J Cardiol 62:635–637
Simpson AJ, Booth NA, Moore NR, Bennett B (1991) Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol 44:139–143
Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ (1992) Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 89:6998–7002
Horie T, Sekiguchi M, Hirosawa K (1978) Coronary thrombosis in pathogenesis of acute myocardial infarction. Br Heart J 40:153–161
Mimuro J, Schleef RR, Loskutoff DJ (1987) Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood 70:721–728
Owensby DA, Morton PA, Wun TC, Schwartz AL (1991) Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. J Biol Chem 266:4334–4340
Seiffert D, Wagner NN, Loskutoff DJ (1990) Serumderived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor. J Cell Biol 111:1283–1291
Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G (1990) Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem 265:18490–18498
Knudsen BS, Silverstein RL, Leung LLK, Harpel PC, Nachman RL (1986) Binding of plasminogen to extracellular matrix. J Biol Chem 261:10765–10771
Henkin J, Marcotte P, Yang H (1991) The plasminogen-plasmin system. Prog Cardiovasc Dis 34:135–164
Knudsen BS, Nachman RL (1988) Matrix plasminogen activator inhibitor. J Biol Chem 263:9476–9481
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yorimitsu, K., Saito, T., Toyozaki, T. et al. Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction. Heart Vessels 8, 160–162 (1993). https://doi.org/10.1007/BF01744801
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01744801